MAP 2018 - Molecular Analysis for Personalised Therapy

Oncology Meeting Resources

14 Sep - 15 Sep 2018, Paris, France

MAP 2018 - Square

The development of new biotechnologies and their application to Precision Medicine in cancer treatment is a fast-moving field. Understanding molecular alterations, their mechanisms of action and how they can apply to therapy is a challenge in medical oncology and clinical practice.

MAP 2018 is a joint initiative of Cancer Research UK, UNICANCER and ESMO and aims to provide oncologists with expert guidance on interpreting genomic alterations to design tailored treatment programmes for their patients.

Resources from MAP 2018 - Molecular Analysis for Personalised Therapy are available to ESMO member according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity. Meeting programme | Future ESMO meetings

Format available

Soft tissue sarcomas (STS) form a group of rare cancers which accounts for around 1% of tumors. In the era of immunotherapy, little is known on the clinical impact of the immune tumor microenvironment...

Date: 15 Sep 2018
Presenter: Florent Petitprez
Resources: Abstract
Topic: Soft Tissue Sarcomas

Date: 15 Sep 2018
Presenter: Laurence Zitvogel

Date: 15 Sep 2018
Presenter: Alberto Mantovani